文献速递基础与转化研究新药、器械与细胞基因治疗研发

巨噬细胞特异性体内RNA编辑促进小鼠吞噬作用与抗肿瘤免疫

Macrophage-specific in vivo RNA editing promotes phagocytosis and antitumor immunity in mice.
PubMed 文献 · Sci Transl Med · 2025-01-15

研究开发了巨噬细胞特异性编辑(MAGE)系统,利用四臂分支PBAE29载体递送CasRx质粒至巨噬细胞实现RNA编辑。体外实验表明PBAE29转染炎症反应低于传统脂质体或电转,小环质粒可提高转染效率。MAGE系统靶向唾液酸结合免疫球蛋白样凝集素10和信号调节蛋白α转录本,增强巨噬细胞吞噬作用,并在小鼠肿瘤模型(含人源化小鼠患者来源胰腺腺癌异种移植)中刺激抗肿瘤免疫、缩小肿瘤体积。

要点

  • MAGE系统通过PBAE29载体递送CasRx编辑巨噬细胞RNA,体外转染炎症水平低于传统方法
  • 靶向唾液酸结合免疫球蛋白样凝集素10和信号调节蛋白α可增强巨噬细胞吞噬作用
  • MAGE系统在小鼠肿瘤模型中刺激抗肿瘤免疫并缩小肿瘤体积

核心结论

  • MAGE系统为体内巨噬细胞特异性递送RNA编辑工具提供了有前景的平台,可作为癌症治疗应用。

研究设计与样本

  • 研究开发了巨噬细胞特异性编辑(MAGE)系统,利用聚(β-氨基酯)(PBAE)载体递送编码CasRx的紧凑质粒DNA至巨噬细胞,在体外和体内进行RNA编辑。

主要发现

  • 鉴定出四臂分支PBAE29(1-(2-氨基乙基)-4-甲基哌嗪封端)可实现高效巨噬细胞转染。
  • PBAE29转染培养巨噬细胞产生的炎症细胞因子和炎症小体激活少于传统脂质体或电转介导的质粒递送。
  • 小环质粒递送CasRx进一步提高转染效率。
  • MAGE系统靶向唾液酸结合免疫球蛋白样凝集素10和信号调节蛋白α转录本实现有效蛋白敲低,改善巨噬细胞吞噬作用。
  • MAGE系统在体内靶向巨噬细胞,刺激抗肿瘤免疫反应并缩小小鼠肿瘤模型(包括人源化小鼠患者来源胰腺腺癌异种移植)的肿瘤体积。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Macrophages play a central role in antitumor immunity, making them an attractive target for gene therapy strategies. However, macrophages are difficult to transfect because of nucleic acid sensors that can trigger the degradation of foreign plasmid DNA. Here, we developed a macrophage-specific editing (MAGE) system by which compact plasmid DNA encoding a CasRx editor can be delivered to macrophages by a poly(β-amino ester) (PBAE) carrier to bypass the DNA sensor and enable RNA editing in vitro and in vivo. We identified a four-arm branched PBAE with 1-(2-aminoethyl)-4-methylpiperazine end-capping (PBAE29) that enables highly efficient macrophage transfection. PBAE29-mediated transfection of cultured macrophages stimulated less inflammatory cytokine production and inflammasome activation compared with traditional lipofectamine or electroporation-mediated plasmid delivery. Transfection efficiency was further improved by delivering CasRx by minicircle plasmid. The MAGE system incorporated a layer of carboxylated-mannan coating to target macrophage mannose receptors and a macrophage-specific promoter for enhanced selectivity. The delivery of CasRx with guide RNA targeting the transcripts for sialic acid-binding immunoglobulin similar to lectin 10 and signal regulatory protein alpha expression resulted in effective protein knockdown, improving macrophage phagocytosis. The MAGE system also showed efficacy in targeting macrophages in vivo, stimulating antitumor immune responses and reducing tumor volume in murine tumor models, including patient-derived pancreatic adenocarcinoma xenografts in humanized mice. In sum, the MAGE system presents a promising platform for in vivo macrophage-specific delivery of RNA editing tools that can be applied as a cancer therapy.

来源:Sci Transl Med,查看原文。版权归原作者所有。

引用

  1. Chen Y, Chen X, Zhang Y, et al. Macrophage-specific in vivo RNA editing promotes phagocytosis and antitumor immunity in mice. Sci Transl Med. 2025. PMID: 39813319. doi:10.1126/scitranslmed.adl5800

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。